Differential miRNA expression in the peripheral blood of patients with Keshan disease and its mechanism
10.3760/cma.j.cn231583-20210227-00054
- VernacularTitle:克山病患者外周血miRNA表达差异及其机制探讨
- Author:
Yong LIU
1
;
Youzhang XIANG
;
Jingwen LIU
;
Guanfeng CHONG
;
Yuehai WANG
;
Guangyong HUANG
Author Information
1. 山东大学附属聊城市人民医院心内科 252000
- Keywords:
Keshan disease;
miRNA;
RNA-seq technology;
Transcriptomics
- From:
Chinese Journal of Endemiology
2021;40(8):610-615
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Through differential miRNA expression profiles and bioinformatics in the peripheral blood of patients with Keshan disease (KD) and healthy control, to explore the possible pathogenesis of KD.Methods:Ten patients with chronic KD (KD group) were selected in the severe disease area of KD in Wulian County, and 10 healthy subjects (control group) were selected in non-KD area of Dongchangfu District, Shandong Province. Blood sample of elbow vein was collected and plasma was separated. RNA-seq technology was used to construct the differential expression profiles of miRNA in KD and control groups. Target mRNAs were screened using Starbase, miRTarBase, miRDB and TargetScan. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted to investigate the possible pathogenesis of KD.Results:Compared the control group and KD group, 132 differentially expressed miRNAs were screened out, including 90 upregulated and 42 downregulated miRNAs. Through Starbase, miRTarBase, miRDB and TargetScan, 53 miRNAs were obtained, 737 targeted mRNAs were obtained. GO analysis showed that the differential genes were mainly involved in the biological processes of Ras protein signal transduction, transmembrane transport, cell cycle regulation, cell adhesion, etc. KEGG pathway analysis showed that the differential genes were mainly involved in viral infection, endocytosis, adhesion spot and actin regulation.Conclusion:In this study, RNA-seq technology is used to obtain differential miRNA expression profiles of KD patients and healthy control, and target pathogenic genes and signaling pathways that may be related to KD are screened out.
